
Alibaba Health Information Technology Limited
ALBBY | OTC
$7.35
+$0.24 (+3.38%)
At close: Oct 30, 2026, 3:58 PM ET
$7.35
$0.00 (-0.06%)
After-hours:
Oct 30, 2026, 5:00 PM ET
TTM Period Ending | Q4 2026 Mar 31, 2026 | Q2 2026 Sep 30, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q4 2023 Mar 31, 2023 | Q2 2023 Sep 30, 2022 | Q4 2022 Mar 31, 2022 | Q2 2022 Sep 30, 2021 | Q4 2021 Mar 31, 2021 | Q2 2021 Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 42.42B | 24.86B | 15.3B | 14.17B | 35.25B | 28.22B | 26.76B | 22.72B | 20.58B | 17.71B | 15.52B | 12.64B |
Cost of Revenue | 32.26B | 18.73B | 11.58B | 10.89B | 27.47B | 21.95B | 21.06B | 18.18B | 16.47B | 14.08B | 11.9B | 9.59B |
Gross Profit | 10.16B | 6.13B | 3.72B | 3.28B | 7.78B | 6.27B | 5.7B | 4.54B | 4.11B | 3.63B | 3.62B | 3.05B |
Operating Income | 2.18B | 1.47B | 739.26M | 581.96M | 435.97M | 246.7M | -51.5M | -545.46M | -1.1B | -775.74M | 37.47M | 163.15M |
Interest Income | 574.5M | 348.38M | 242.98M | 266M | 534.84M | 384.47M | 325.76M | 263.43M | 209.76M | 191.44M | 164.33M | 101.36M |
Pretax Income | 2.64B | 1.8B | 779.98M | 639.6M | 1.09B | 858.29M | 550.99M | 151.32M | -252.51M | -153.08M | 401.22M | 327.91M |
Net Income | 2.27B | 1.6B | 716.21M | 603.27M | 1.04B | 819.35M | 535.65M | 128.41M | -265.56M | -166.61M | 348.59M | 277.95M |
Selling & General & Admin | 6.99B | 4.15B | 2.62B | 2.35B | 6.47B | 5.34B | 5.06B | 4.35B | 4.47B | 3.87B | 3.14B | 2.54B |
Research & Development | 988.76M | 513.51M | 360.03M | 352.64M | 866.18M | 673.15M | 677.82M | 730.06M | 728.83M | 516.93M | 423.63M | 347.15M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 7.98B | 4.66B | 2.98B | 2.7B | 7.12B | 5.8B | 5.48B | 4.65B | 4.57B | 3.98B | 3.38B | 2.82B |
Interest Expense | 1.35M | 654.37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 3.09B | 1.83B | 1.62B | 1.43B | 2.23B | 1.78B | 1.77B | 1.86B | 1.98B | 1.7B | 1.22B | 898.21M |
Cost & Expenses | 40.23B | 23.39B | 14.56B | 13.59B | 34.59B | 27.74B | 26.54B | 22.83B | 21.04B | 18.06B | 15.28B | 12.42B |
Income Tax Expense | 375.84M | 200.81M | 63.98M | 36.08M | 50.21M | 40.15M | 14.49M | 22.19M | 13.43M | 14.36M | 58.54M | 57.42M |
Shares Outstanding (Basic) | 16.2B | 16.2B | 16.18B | 16.09B | 14.63B | 13.55B | 13.54B | 13.52B | 13.49B | 13.48B | 13.45B | 13.12B |
Shares Outstanding (Diluted) | 16.2B | 16.2B | 16.18B | 16.1B | 14.63B | 13.55B | 13.56B | 13.52B | 13.49B | 13.48B | 13.53B | 13.12B |
EPS (Basic) | 0.14 | 0.10 | 0.04 | 0.04 | 0.08 | 0.06 | 0.04 | 0.01 | -0.02 | -0.01 | 0.03 | 0.02 |
EPS (Diluted) | 0.14 | 0.10 | 0.04 | 0.04 | 0.08 | 0.06 | 0.04 | 0.01 | -0.02 | -0.01 | 0.03 | 0.02 |
EBITDA | 1.84B | 1.51B | 784.92M | 628.16M | 515.04M | 299.71M | 11.63M | -472.26M | -1.04B | -733.95M | 70.56M | 196.16M |
EBIT | 1.75B | 1.46B | 726.81M | 573.6M | 434.09M | 246.7M | -51.5M | -545.46M | -1.1B | -775.74M | 37.47M | 163.15M |
Depreciation & Amortization | 84.51M | 54.87M | 58.12M | 54.56M | 80.96M | 53.01M | 63.13M | 73.19M | 60.53M | 41.8M | 33.09M | 33M |
Add to Watchlist
Select watchlists to add or remove ALBBY